{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:54:36Z","timestamp":1790794476129,"version":"4.1.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2026-0026_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate biochemical, hormonal, genetic, and mitochondrial alterations associated with cardiovascular risk in SCH, emphasizing the interplay between NT-proBNP, succinate dehydrogenase (SDH) complex activity, and thyroid-stimulating hormone receptor (TSHR) gene expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0026_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case\u2013control study was conducted involving SCH patients and age-matched euthyroid controls. Serum thyroid profiles, NT-proBNP, and SDH complex activity were quantified by standard assays, and TSHR gene expression was measured using RT-PCR. Receiver operating characteristic (ROC) analyses assessed diagnostic performance, and multiple linear regression identified independent predictors of TSHR expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0026_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with controls, SCH cases showed significantly higher TSH and NT-proBNP levels, reduced SDH complex activity, and upregulated TSHR gene expression (p&lt;0.05). ROC analysis demonstrated excellent diagnostic accuracy for NT-proBNP, SDHA, and TSHR expression. After adjustment for confounders, SDH complex activity remained the only independent predictor of TSHR expression, whereas NT-proBNP lost independent significance, suggesting an indirect or interaction-mediated effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0026_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SDHA serves as a robust independent predictor of cardiovascular risk in SCH, highlighting mitochondrial dysfunction in thyroid receptor regulation. NT-proBNP showed predictive potential but not independent significance, indicating secondary modulation by hormonal or metabolic factors. Larger longitudinal studies are warranted for validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2026-0026","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:55:47Z","timestamp":1790790947000},"source":"Crossref","is-referenced-by-count":0,"title":["TSHR gene expression and mitochondrial-cardiac interactions as emerging predictors of cardiovascular risk in early thyroid dysfunction"],"prefix":"10.1515","author":[{"given":"Manjusha","family":"Kottola","sequence":"first","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-662X","authenticated-orcid":false,"given":"Desigamani","family":"Kanniyappan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Madha Medical College and Hospital , Kovur, Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodaran","family":"Boopathi","sequence":"additional","affiliation":[{"name":"Department of Psychology , Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyapal","family":"Vidhyadharan","sequence":"additional","affiliation":[{"name":"Hridayalaya Heart and Robotic Research Centre Pvt-Ltd. , Thiruvananthapuram , Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjitha","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshma","family":"Retnakaran","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joby Paruthiparayil","family":"Jose","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisha Anjali","family":"Madhavan Pillai","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to Be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7124-148X","authenticated-orcid":false,"given":"Dinesh Roy","family":"Divakaran","sequence":"additional","affiliation":[{"name":"Genetika, Centre for Advanced Genetic Studies , Thiruvananthapuram , Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026093017554426689_j_hmbci-2026-0026_ref_001","doi-asserted-by":"crossref","unstructured":"Ross, DS, Burch, HB, Cooper, DS, Greenlee, MC, Laurberg, P, Maia, AL et al.. American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid\u00ae 2016;26:1343\u2013421. https:\/\/doi.org\/10.1089\/thy.2016.0229.","DOI":"10.1089\/thy.2016.0229"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_002","doi-asserted-by":"crossref","unstructured":"Marvisi, M, Zambrelli, P, Brianti, M, Civardi, G, Lampugnani, R, Delsignore, R. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur J Intern Med 2006;17:267\u201371. https:\/\/doi.org\/10.1016\/j.ejim.2005.11.023.","DOI":"10.1016\/j.ejim.2005.11.023"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_003","doi-asserted-by":"crossref","unstructured":"Kleinau, G, Worth, CL, Kreuchwig, A, Biebermann, H, Marcinkowski, P, Scheerer, P, et al.. Structural-functional features of the thyrotropin receptor: a class A G-protein-coupled receptor at work. Front Endocrinol 2017;8:86. https:\/\/doi.org\/10.3389\/fendo.2017.00086.","DOI":"10.3389\/fendo.2017.00086"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_004","doi-asserted-by":"crossref","unstructured":"Furmaniak, J, Sanders, J, Miguel, RN, Smith, BR. Mechanisms of action of TSHR autoantibodies. Horm Metab Res 2015;47:735\u201352. https:\/\/doi.org\/10.1055\/s-0035-1559648.","DOI":"10.1055\/s-0035-1559648"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_005","doi-asserted-by":"crossref","unstructured":"Ahmadi, N, Ahmadi, F, Sadiqi, M, Ziemnicka, K, Minczykowski, A. Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature. Endokrynol Pol 2020;71:466\u201378. https:\/\/doi.org\/10.5603\/ep.a2020.0052.","DOI":"10.5603\/EP.a2020.0052"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_006","doi-asserted-by":"crossref","unstructured":"Gheorghiu, ML, Badiu, C. Selenium involvement in mitochondrial function in thyroid disorders. Hormones (Basel) 2020;19:25\u201330. https:\/\/doi.org\/10.1007\/s42000-020-00173-2.","DOI":"10.1007\/s42000-020-00173-2"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_007","doi-asserted-by":"crossref","unstructured":"Pingitore, A, Gaggini, M, Mastorci, F, Sabatino, L, Cordiviola, L, Vassalle, C. Metabolic syndrome, thyroid dysfunction, and cardiovascular risk: the triptych of evil. Int J Mol Sci 2024;25:10628. https:\/\/doi.org\/10.3390\/ijms251910628.","DOI":"10.3390\/ijms251910628"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_008","doi-asserted-by":"crossref","unstructured":"Richards, AM. N-terminal B-type natriuretic peptide in heart failure. Heart Fail Clin 2018;14:27\u201339. https:\/\/doi.org\/10.1016\/j.hfc.2017.08.004.","DOI":"10.1016\/j.hfc.2017.08.004"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_009","doi-asserted-by":"crossref","unstructured":"Yang, Y, Zmuda, JM, Wojczynski, MK, Thyagarajan, B, Christensen, K, Cvejkus, RK, et al.. Genetic association analysis of the cardiovascular biomarker: N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP). PLoS One 2021;16:e0248726. https:\/\/doi.org\/10.1371\/journal.pone.0248726.","DOI":"10.1371\/journal.pone.0248726"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_010","doi-asserted-by":"crossref","unstructured":"Jabbar, A, Pingitore, A, Pearce, SH, Zaman, A, Iervasi, G, Razvi, S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 2017;14:39\u201355. https:\/\/doi.org\/10.1038\/nrcardio.2016.174.","DOI":"10.1038\/nrcardio.2016.174"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_011","doi-asserted-by":"crossref","unstructured":"Paschou, SA, Bletsa, E, Stampouloglou, PK, Tsigkou, V, Valatsou, A, Stefanaki, K, et al.. Thyroid disorders and cardiovascular manifestations: an update. Endocrine 2022;75:672\u201383. https:\/\/doi.org\/10.1007\/s12020-022-02982-4.","DOI":"10.1007\/s12020-022-02982-4"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_012","doi-asserted-by":"crossref","unstructured":"Cappola, AR, Desai, AS, Medici, M, Cooper, LS, Egan, D, Sopko, G, et al.. Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment. Circulation 2019;139:2892\u2013909.","DOI":"10.1161\/CIRCULATIONAHA.118.036859"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_013","doi-asserted-by":"crossref","unstructured":"Stojkovi\u0107, M, \u017darkovi\u0107, M. Subclinical thyroid dysfunction and the risk of cardiovascular disease. Curr Pharm Des 2020;26:5617\u201327. https:\/\/doi.org\/10.2174\/1381612826666201118094747.","DOI":"10.2174\/1381612826666201118094747"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_014","doi-asserted-by":"crossref","unstructured":"Zhang, H, Li, X, Zhang, N, Tian, L. Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: a systematic review and meta-analysis. Front Endocrinol 2023;14:1083171. https:\/\/doi.org\/10.3389\/fendo.2023.1083171.","DOI":"10.3389\/fendo.2023.1083171"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_015","doi-asserted-by":"crossref","unstructured":"Cao, Z, Jia, Y, Zhu, B. BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. Int J Mol Sci 2019;20:1820. https:\/\/doi.org\/10.3390\/ijms20081820.","DOI":"10.3390\/ijms20081820"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_016","doi-asserted-by":"crossref","unstructured":"Zhao, X, Zhang, R, Jiang, H, Liu, K, Ma, C, Bai, M, et al.. Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure. BMC Endocr Disord 2021;21:140. https:\/\/doi.org\/10.1186\/s12902-021-00801-x.","DOI":"10.1186\/s12902-021-00801-x"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_017","doi-asserted-by":"crossref","unstructured":"Neves, JS, Fontes-Carvalho, R, Borges-Canha, M, Leite, AR, von Hafe, M, Vale, C, et al.. Association of thyroid function, within the euthyroid range, with cardiovascular risk: the EPIPorto study. Front Endocrinol 2022;13:1067801. https:\/\/doi.org\/10.3389\/fendo.2022.1067801.","DOI":"10.3389\/fendo.2022.1067801"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_018","doi-asserted-by":"crossref","unstructured":"Barasch, E, Gottdiener, J, Buzkova, P, Cappola, A, Shah, S, DeFilippi, C, et al.. Association of thyroid dysfunction in individuals\u00a0\u2265 65\u00a0years of age with subclinical cardiac abnormalities. J\u00a0Clin Endocrinol Metabol 2024;109:e1847\u201356. https:\/\/doi.org\/10.1210\/clinem\/dgae001.","DOI":"10.1210\/clinem\/dgae001"},{"key":"2026093017554426689_j_hmbci-2026-0026_ref_019","doi-asserted-by":"crossref","unstructured":"Forini, F, Nicolini, G, Iervasi, G. Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine. Int J Mol Sci 2015;16:6312\u201336. https:\/\/doi.org\/10.3390\/ijms16036312.","DOI":"10.3390\/ijms16036312"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0026\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:55:50Z","timestamp":1790790950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0026\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":19,"alternative-id":["10.1515\/hmbci-2026-0026"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2026-0026","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}